Dr. Somasundaram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514
Education & Training
University of Texas Southwestern Medical SchoolClass of 2013
Certifications & Licensure
NC State Medical License 2021 - 2030
PA State Medical License 2018 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer Start of enrollment: 2019 Jun 12
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy.Dylan Fortman, Hong Wang, Robert VanderWeele, Terry Evans, James G Herman
Clinical Lung Cancer. 2025-01-01 - 1 citationsFuture of Dendritic Cell-Based Approaches in Pancreatic Cancer.Ashwin Somasundaram, Jen Jen Yeh
Journal of Clinical Oncology. 2024-09-10 - PD-1 blockade is a promising therapeutic addition to neoadjuvant chemoradiation in locally advanced rectal cancer.Ashwin Somasundaram, Hanna K Sanoff
Cancer Cell. 2024-09-09
Press Mentions
Rashid Awarded Grant to Develop AI Tool That Recommends Optimal Clinical Trials to Pancreatic Cancer PatientsSeptember 24th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
